EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-assembled peptide RADA16 hydrogel supports wound epithelialization by a laminin-332-dependent binding mechanism

Chloé Laigle, Marie Buffier, Emélie Clémens, Sharanya Sankar, Patricia Rousselle

Acta Biomaterialia · 2026-01 · 209 · 194-210

DOI: 10.1016/j.actbio.2025.09.055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-01. Verfasst von Chloé Laigle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305; CNRS; Univ. Lyon 1; SFR BioSciences Gerland-Lyon Sud; 7 passage du Vercors,…. Hauptthemen laut MEDLINE: Peptides, Hydrogels, Re-Epithelialization, Cell Adhesion Molecules. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Medical Research, Association Nationale de la Recherche et de la Technologie, Région Auvergne-Rhône-Alpes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Re-epithelialization describes the resurfacing of a skin wound with new epidermis as the first step in restoring its integrity and barrier function. In wounds, re-epithelialization progresses from the surrounding wound edges towards the center, forming a continuum in the regeneration of a differentiated epidermis by adhesion to extracellular matrix proteins. Failure of re-epithelialization is a hallmark of chronic wounds and keeps them in a vicious cycle of infection and uncontrolled inflammation that impairs healing. With the increasing number of all forms of chronic wounds, there is an urgent need to develop appropriate therapeutics. To address the lack of a therapeutic solution specifically targeting this burden, we focused on the self-assembling peptide hydrogel RADA16, whose biocompatibility and therapeutic validation for use in humans as a hemostatic agent make it an attractive candidate. Due to its ability to adopt different stiffness and stability properties depending on the peptide concentration, we investigated its most promising formulation to support epidermal regeneration. Our study shows that RADA16 is a scaffold that permits keratinocyte adhesion, proliferation and migration, enabling wound closure both in vitro and in vivo. We demonstrate an effect based on RADA16-specific binding to the keratinocyte major adhesion protein laminin-332, which is essential for these cellular processes. Our study describes the RADA16 hydrogel as the first synthetic, hydrating, stable and resorbable hydrogel that fosters re-epithelialization of wounds through an endogenous and spontaneous laminin-332 binding mechanism. STATEMENT OF SIGNIFICANCE: The study reports on the characterization of a self-assembling peptide hydrogel (RADA16), already in clinical use for its hemostatic properties, with a view to its use for the reepithelialization of skin wounds. The focus on this indication is important as there is currently no hydrogel with healing-promoting properties in clinical practice. The work is significant as it provides an in-depth investigation of the mechanism by which RADA16 supports wound resurfacing, based on its endogenous and spontaneous interaction with the extracellular matrix protein laminin-332, the major adhesion protein produced by epidermal cells. The combination of basic research for therapeutic development with consideration of a global public health problem are assets that characterize this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesHydrogelsRe-EpithelializationCell Adhesion MoleculesWound HealingHumansAnimalsKeratinocytesKalininCell AdhesionCell ProliferationMiceCell MovementProtein Binding

Stichwörter der Autor:innen

Auto-assembling peptideEpidermisKeratinocyteLaminin-332Re-epithelializationWound healing

Substanzen

PeptidesHydrogelsKalininCell Adhesion MoleculesRADA16-I

Autor:innen und Institutionen

  • Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305; CNRS; Univ. Lyon 1; SFR BioSciences Gerland-Lyon Sud; 7 passage du Vercors, 69367, Lyon, France.
  • 3-D Matrix Europe SAS, 11 chemin des Petites Brosses, 69300, Caluire-et-Cuire, France.
  • Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305; CNRS; Univ. Lyon 1; SFR BioSciences Gerland-Lyon Sud; 7 passage du Vercors, 69367, Lyon, France. Electronic address: patricia.rousselle@cnrs.fr.

Förderung

  • Foundation for Medical Research
  • Association Nationale de la Recherche et de la Technologie
  • Région Auvergne-Rhône-Alpes
  • Horizon 2020 Framework Programme

Zitieren

APA

Laigle, C., Buffier, M., Clémens, E., Sankar, S., & Rousselle, P. (2026). Self-assembled peptide RADA16 hydrogel supports wound epithelialization by a laminin-332-dependent binding mechanism. Acta Biomaterialia, 209, 194-210. https://doi.org/10.1016/j.actbio.2025.09.055

Vancouver

Laigle C, Buffier M, Clémens E, Sankar S, Rousselle P. Self-assembled peptide RADA16 hydrogel supports wound epithelialization by a laminin-332-dependent binding mechanism. Acta Biomaterialia. 2026;209:194-210. doi:10.1016/j.actbio.2025.09.055

BibTeX
@article{Laigle2026,
  author = {Laigle, Chloé and Buffier, Marie and Clémens, Emélie and Sankar, Sharanya and Rousselle, Patricia},
  title = {Self-assembled peptide RADA16 hydrogel supports wound epithelialization by a laminin-332-dependent binding mechanism},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {209},
  pages = {194--210},
  doi = {10.1016/j.actbio.2025.09.055}
}
Kostenlos starten →